Matson Evaluation of Drug Side-Effects (MEDS) Profiles of Selective Serotonin Reuptake Inhibitors (SSRI) in Adults with Intellectual Disability-Reference-Cited by-同舟云学术

Matson Evaluation of Drug Side-Effects (MEDS) Profiles of Selective Serotonin Reuptake Inhibitors (SSRI) in Adults with Intellectual Disability

Published:2008-11-15 Issue:1 Volume:21 Page:57-68
ISSN:1056-263X
Container-title:Journal of Developmental and Physical Disabilities
language:en
Short-container-title:J Dev Phys Disabil

Author:

Matson Johnny L.,Rivet Tessa T.,Fodstad Jill C.

Publisher

Springer Science and Business Media LLC

Subject

Developmental and Educational Psychology,Physical Therapy, Sports Therapy and Rehabilitation

Link

http://link.springer.com/content/pdf/10.1007/s10882-008-9125-5.pdf

Reference26 articles.

1. Advokat, C. D., Mayville, E. A., & Matson, J. L. (2000). Side effect profiles of atypical antipsychotics, typical antipsychotics, or no psychotropic medications in persons with mental retardation. Research in Developmental Disabilities, 21(1), 75–84. doi: 10.1016/S0891-4222(99)00031-1 .

2. American Psychiatric Association [APA] (2000). Diagnostic and statistical manual of mental disorders (4th ed.) - text revision. Washington, D.C.: APA.

3. Biswas, A. B., Bhaumik, S., & Branford, D. (2001). Treatment-emergent behavioural side effects with selective serotonin re-uptake inhibitors in adults with learning disabilities. Human Psychopharmacology: Clinical & Experimental, 16(2), 133–137. doi: 10.1002/hup.233 .

4. Garcia, M., & Matson, J. (2008). Akathisia in adults with severe and profound intellectual disability: A psychometric study of the MEDS and ARMS. Journal of Intellectual & Developmental Disability, 33(2), 171–176. doi: 10.1080/13668250802065190 .

5. Janowsky, D., & Davis, J. M. (2005). Diagnosis and treatment of depression in patients with mental retardation. Current Psychiatry Reports, 7(6), 421–428. doi: 10.1007/s11920-005-0062-z .

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rating scales to measure adverse effects of medications in people with intellectual disability: a scoping review;European Journal of Clinical Pharmacology;2022-08-31

2. Depression Treatment Evidence and Application to Individuals with Intellectual Disability;Handbook of Dual Diagnosis;2020

3. Psychotropic medications and adults with intellectual disabilities: care staff perspectives;Advances in Mental Health and Intellectual Disabilities;2013-11-18

4. An investigation of self-injurious behaviors in adults with severe intellectual disabilities;Research in Developmental Disabilities;2013-09

5. ‘Counterfeit Deviance’ Revisited;Journal of Applied Research in Intellectual Disabilities;2013-08-08